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Abstract Chiasmal dysfunction produces a characteristic
clinical picture, regardless of the mechanism. In most cases
a compressive lesion is the cause. In occasional cases, how-
ever, no such extrinsic mass is found and other possible
etiologies must be explored. In some of these cases, the
pathologic process is identifiable with appropriate neuroim-
aging. For example, inflammation, infiltrative tumors, and
radiation necrosis produce intrinsic chiasmal enhancement.
Chiasmal ischemia may require specialized magnetic reso-
nance (MR) sequences for diagnosis. Chiasmal hemorrhage,
trauma and chiasmal herniation typically produce distinctive
changes on noncontrasted imaging. In cases of metabolic
insult, either toxic or hereditary, radiographic changes are
typically absent. In each of these, the correct diagnosis can
usually be made with a combination of clinical and radio-
graphic features.
Keywords Opticchiasm .Chiasm .Opticnerve .Chiasmitis .
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Introduction
A chiasmal lesion is suspected when bilateral temporal visual
field loss, partial or complete, is observed. Patients are often
asymptomatic or have nonspecific visual difficulties until
central visual dysfunction occurs. When bitemporal loss is
complete, odd visual phenomena may occur. "Hemifield
slide" occurs when the remaining nasal hemifields fail to
maintain alignment along the vertical meridian, slipping apart
vertically or horizontally [1, 2]. This occurs because of insuf-
ficient corresponding retinal points needed to maintain fusion.
Patients with hemifield slide complain of intermittent diplo-
pia, poor depth perception, and gaps in straight lines. Despite
this lack of overlapping fields, prismatic and/or surgical cor-
rection of a manifest strabismus can improve fusional capacity
and reduce symptoms in such patients [1, 2].
Another interesting phenomenon secondary to bitemporal
hemianopsia is "post-fixational blindness". This is a distur-
bance of depth perception, particularly bothersome during
near work. When fixating a target, the area distal to the target
is viewed only with overlapping temporal hemifields which,
in this case, are nonseeing. Thus, the patient is blind for all
objects beyond the point of fixation. The area in front of the
target is viewed within the intact nasal hemifields, permitting
binocular vision. Patients with postfixational blindness com-
plain that objects appear and disappear as they change their
point of fixation [3].
The large majority of lesions causing chiasmal visual loss
are extrinsic masses which compress the chiasm, most com-
monly pituitary adenoma, suprasellar meningioma, or
craniopharyngioma. Yet, there are important causes of
chiasmal visual loss that are not due to an extrinsic mass and
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these intrinsic or otherwise noncompressive lesions form the
basis of this review.
Chiasmal Inflammation
As in optic neuritis, inflammation of the optic chiasm is most
often a demyelinating disorder [4] (Fig. 1a). Occasional cases
are due to a specific infectious/inflammatory systemic disor-
der or occur shortly after a viral illness or immunization [5].
Specific causes of chiasmal inflammation include Epstein
Barr virus, mumps, Lyme disease, systemic lupus erythema-
tosus, varicella zoster, sarcoidosis, and Langherhans
histiocytosis [6–12].
Demyelinating chiasmal neuritis occurs as an isolated idi-
opathic event [4] or as part of relapsing-remitting multiple
sclerosis (MS), acute demyelinating encephalomyelitis or neu-
romyelitis optica [13, 14]. Demographic features of idiopathic
demyelinating chiasmal neuritis resemble those of optic neu-
ritis, showing a strong female predilection [4]. Most cases
occur in adults but idiopathic chiasmal optic neuritis has been
reported in patients as young as 4 years of age [15•]. In
contrast to optic neuritis, pain is infrequent, reported by only
20 % of patients in 1 large series (vs 90 % of patients with
optic neuritis) [4]. Positive visual phenomena were reported
by 25 % of patients, often accompanied by light sensitivity.
The temporal course of chiasmal neuritis is also similar to that
of optic neuritis, vision worsening for days to weeks then
stabilizing with eventual substantial improvement. In the larg-
est series, consisting of 20 patients with idiopathic chiasmal
neuritis reported by Kawasaki and Purvin, 97 % of patients
had final visual acuity of 20/40 or better [4]. However, 40 %
developed clinically definite MS from 3 months to 3 years
after onset of visual loss, usually within the first year.
In addition to intrinsic inflammation as described above,
the chiasm is sometimes affected by an adjacent inflammatory
process. For example, inflammation of the meninges may
involve the chiasm, with etiologies including tuberculosis
[16, 17], rheumatoid pachymeningitis [18], Wegener’s granu-
lomatosis [19], and syphilis. Lymphocytic hypophysitis is due
to an autoimmune attack on the pituitary gland and stalk, most
commonly occurring during pregnancy. In this form of peri-
chiasmal inflammation visual loss can be due to spread of the
inflammatory process to involve the chiasm or compression
by the inflamed pituitary stalk [20].
Vascular
Recent advances in neuroimaging have increased our ability
to detect and define ischemia of the anterior visual pathways
[21]. Specifically, the addition of diffusion weighted imaging
(DWI) and diffusion tensor imaging (DTI) [22, 23] are
particularly valuable in this setting. DTI, which uses multiple
diffusion directions of analysis and has a higher signal to noise
ratio, is especially sensitive.
Despite this increased sensitivity, infarction of the optic
chiasm is an uncommon diagnosis. Because of its complex
and redundant vascular supply, the chiasm is relatively resis-
tant to ischemia. Two cases of embolic chiasmal infarction
have been described, 1 following open heart surgery [23] and
the other because of atrial fibrillation [24•]. In addition, an
iatrogenic case because of embolism occurred during treat-
ment of an ophthalmic segment aneurysm in which there was
occlusion of the superior hypophyseal artery [25].
In addition to infarction, vascular damage to the optic
chiasm can be caused by hemorrhage, either from an extrinsic
mass, typically a pituitary tumor (termed pituitary apoplexy)
or from an intrinsic lesion, most often a cavernous malforma-
tion (termed chiasmal apoplexy) (Fig. 1c). Patients with
chiasmal apoplexy typically present with acute bilateral visual
loss and headache. In a large series of patients with cavernous
malformations (CM) involving the optic pathways, there was
evidence of old or chronic bleeding in 15 % [26]. Most
patients are treated with surgical resection, often with good
visual outcome. Rarely, hemorrhage within the chiasm is
caused by an intrinsic tumor such as glioma [27].
Neoplasm
Optic pathway glioma is usually a disease of childhood. The
majority of cases are sporadic but the association of this tumor
with neurofibromatosis type 1 is clear. Extension to involve
the chiasm occurs in 40 %–70 % of cases, more commonly in
the sporadic form (Fig. 2a and b). Patients with chiasmal
glioma usually have slowly progressive bitemporal visual
loss, occasionally associated with hormonal disturbance and/
or hydrocephalus due to exophytic extension. Such extension
is more common in sporadic case [28, 29]. Optic pathway
glioma in childhood most often follows a benign course,
prompting debate regarding pathologic classification as tumor
vs hamartoma.
In contrast to its limited growth potential in childhood,
optic pathway glioma in older adults has an aggressive course,
consistent with its pathologic features of high grade malig-
nancy. These patients present with acute onset of visual loss
that may be mistaken for optic neuritis or ischemic optic
neuropathy [30–32]. Tumors that are initially confined to 1
intra-orbital optic nerve typically show subsequent progres-
sion to the chiasm and then tracts; in occasional cases the
chiasm is the initial site of the tumor [31] (Fig. 2c and d). The
typical course includes rapid progression leading to blindness
within weeks and death within months. Optic nerve and
chiasmal infiltration can also occur in multifocal glioma,
termed gliomatosis cerebri [33]. Such anterior visual pathway
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involvement occurs in approximately 10 % of cases and may
be mistaken for multiple sclerosis [34].
Management of optic nerve glioma in children and young
adults has been controversial, largely because of its variable
growth potential. Initial observation is the preferred strategy,
embarking on treatment in response to clinical worsening, not
necessarily on radiographic growth alone. Listernick simpli-
fied the definition of ophthalmologic progression to be either:
a 2-line change in Snellen, HOTVor Lea visual acuity or a 2-
octave decline in Teller acuity [35].
The extent of posterior extension is sometimes used to
direct treatment. Specifically, resection of an involved intra-
cranial optic nerve is sometimes undertaken if the tumor is
progressing and is thought to terminate anterior to the optic
chiasm. MRI is the standard noninvasive method for making
this determination. However, a recent study of 13 such pa-
tients who were studied with MRI and subsequently
underwent surgery found that in 5 patients tumor extended
into the chiasm despite an MRI appearance suggesting the
contrary [36•]. Diffusion tensor tractography has also been
used to obtain more detailed information about the
relationship of visual fibers to tumor in patients with optic
pathway gliomas of childhood [37].
Rarely, chiasmal infiltration is due to metastatic tumor.
Isolated infiltration of the optic chiasm by a primary central
nervous system large B-cell lymphoma most often occurs in
the setting of immunosuppression [38] (Fig. 1d). In a subset of
patients, diagnosis can be made based on CSF cytopathology,
flow cytometry and immuno-phenotyping (mainly for pan-B
cell markers) but in many cases diagnosis is only possible with
biopsy [39, 40]. Primary intra-chiasmal germinoma [41] and
posterior extension of retinoblastoma [42] have also been
reported.
Toxic Damage to Chiasm
The potential toxic effect of ethambutol on the optic nerve is
well-known and this dose dependent adverse effect may
sometimes extend to the chiasm. The incidence of optic neu-
ropathy is reportedly <1 % at doses of 15 mg/kg/day, and as
high as 18 %–50 % at >35 mg/kg/day [43, 44]. Conditions
Fig. 1 Examples of
noncompressive chiasmal lesions.
a, Chiasmal optic neuritis in a 32-
year-old woman with acute
bilateral visual blur. Visual acuity
was 20/20 in each eye but
dyschromatopsia and a
bitemporal visual field defect
were found. Post-contrast T1-
weighted coronal MRI shows
mild enlargement and
enhancement of the right side of
the chiasm. b, Chiasmal
herniation following resection of
a large pituitary adenoma.
Coronal MRI shows a thin,
distended chiasm sagging into the
greatly enlarged and «empty»
sella. c, Chiasmal apoplexy in a
35-year-old woman with abrupt
onset of visual loss in the right eye
and a mild temporal defect in the
left eye. This noncontrasted axial
CT shows hyperintensity in the
right side of the chiasm consistent
with hemorrhage. d, Primary
CNS lymphoma in a 42-year-old
man with AIDS. Axial T1-
weighted MRI with gadolinium
shows enlargement of the chiasm
with a ring enhancement pattern
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that increase the risk for ethambutol toxicity include renal or
hepatic insufficiency, older age, diabetes, chronic alcohol, or
tobacco use, and the concomitant use of isoniazid. The mech-
anism of damage is not fully understood but evidence of
copper chelation, zinc accumulation in lysosomes and de-
creased cytosolic calcium suggest compromised mitochondri-
al function in retinal ganglion cells. Kinoshita et al examined
retinal function and morphology in monkeys with ethambutol
toxicity the first paper to describe ethambutol-induced lesions
in the retina [45•]. The authors found severe necrosis of the
retinal ganglion cells in the parafoveal region with a prefer-
ential loss on the nasal side. Outer retinal photoreceptor struc-
ture and function were preserved. This is consistent with a
preferential vulnerability of the papillomacular bundle to eth-
ambutol. Demyelination and glial reaction were noted in the
optic nerves, chiasm, and optic tracts [45•].
Optic nerve and/or chiasmal dysfunction typically occur 2
to 5 months after drug initiation though occasional patients
experience visual loss much earlier, within weeks or even days
of starting treatment. While central or cecocentral scotomas
are the classic visual field defect, ethambutol toxicity can
produce a bitemporal hemianopia. MRI imaging may reveal
abnormal signal changes within the body of the chiasm [46,
47].
Patients should be asked about visual symptoms at each
medical visit and monthly ophthalmic examination is recom-
mended for patients taking >15 mg/kg/day or those at higher
risk of toxicity. Many patients recover some or all visual
function after stopping the drug but in others visual loss
persists and may even continue to worsen. There are no
predictive factors to identify those in whom vision will or will
not recover.
Radiation Damage
Radiation therapy for intracranial or sinus tumors sometimes
damages neighboring structures, including the optic nerve and
chiasm. The site of damage in these cases is most likely the
vascular endothelium. Patients present with sudden, painless
bilateral sequential or simultaneous visual loss that occurs
within 3 years (peak incidence at 12–18 months) following
radiation therapy [48]. Visual loss is rapidly progressive and
severe with more than 85 % of patients having final acuity of
Fig. 2 Examples of chiasmal
glioma. a and b, Benign chiasmal
glioma in a 15-year-old boy with
NF1 and very mild chiasmal
visual loss. Axial and coronal T1-
weighted MR scans show diffuse
enlargement of the chiasm
without enhancement on
postcontrast sequences. c and d,
Malignant glioma of the anterior
visual pathway in a 53-year-old
woman who presented with acute
right optic neuropathy initially
diagnosed as optic neuritis. Over
the next 2 months, her tumor
progressed to involve the entire
pregeniculate visual system and
eventually the brainstem. T1-
weighted axial and coronal MRI
with gadolinium shows
enhancement and enlargement of
the prechiasmal optic nerves, the
chiasm and left optic tract
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20/200 (0.1) or worse. Visual field defects often have a tem-
poral component, indicating chiasmal involvement. MRI
shows enlargement and postcontrast enhancement of the optic
nerves, chiasm, and/or tract.
There is no known effective treatment for radiation-
induced optic neuropathy or chiasmopathy. Anecdotal success
has been reported with hyperbaric oxygen, particularly when
given at higher atmospheres within 72 hours of visual loss
[49•]. Other measures such as anticoagulation and corticoste-
roids are commonly used due to their availability in the urgent
situation, but efficacy has not been proven. Pentoxifylline has
been found to be beneficial in some cases of cerebral
radionecrosis and has, therefore, been tried in radiation optic
neuropathy [50]. Farooq et al described a 24-year-old woman
who lost vision in both eyes over a 2-week period despite
intravenous methylprednisolone [51]. Five years earlier, she
had undergone radiation therapy for tectal tumor. Visual acu-
ity was no light perception in the right eye and 20/100 in the
left eye. Her treatment was changed to a combination of
intravenous bevacizumab plus dexamethasone plus
pentoxifylline and within 2 weeks, vision improved to 20/50
and 20/100 with a partial bitemporal hemianopia. She even-
tually recovered to 20/20 and 20/25 [51]. A similar clinical
recovery was reported by Chahal et al in a patient given a brief
course of dexamethasone and long-term therapy with
pentoxifylline and vitamin E. These 2 reports suggest a po-
tential beneficial effect which is perhaps synergistic between
pentoxifylline and the antivascular endothelial growth factor
bevacizumab. Patients with radiation retinopathy have shown
structural and functional improvement following intravitreal
bevacizumab (Avastin) injection [52]. This benefit, unfortu-
nately, is not sustained, requiring repeat treatment.
Chiasmal Trauma
Situated in a protective niche at the base of the brain, the
chiasm is rarely damaged by trauma. The chiasm is suspended
in the suprasellar cistern about 10 mm above the pituitary
gland which rests in the sella turcica of the sphenoid bone.
Posteriorly, the chiasm borders the anterior inferior wall of the
third ventricle and is flanked by the supraclinoid segments of
the carotid arteries and inferolaterally by the cavernous si-
nuses. The magnitude of head injury associated with chiasmal
trauma is typically severe, resulting in significant damage to
other structures such as the craniofacial bones, hypothalamic-
pituitary axis, clivus, neighboring cranial nerves, and carotid
arteries.
The largest series of patients with chiasmal trauma evalu-
ated at a single institution was reported by Hassan et al and
consisted of 19 patients seen over a 30-year period [53]. The
typical profile was that of a young male (average age 25 years,
range 4–41 years) who had a motor vehicle accident,
accounting for 58 % of cases. Other causes of injury were
falls (21 %), cycling (11 %), horseback riding (5 %), and
assault (5 %). Two-thirds of patients sustained a skull fracture,
most commonly a combined frontal and basilar skull fracture
(31 %) or severe frontal bone fracture (21 %).
There are several possible mechanisms to account for
chiasmal damage secondary to head trauma [54]. One theory
is mechanical disruption of chiasmal fibers. Heinz et al
described 2 patients with bitemporal visual field loss follow-
ing blunt frontal head trauma [55]. Both patients had a
midline basilar skull fracture traversing the midclivus and
continuing through the sella turcica, dorsum sella, and sphe-
noid bone. Such a fracture suggests a sudden and violent
shifting along the longitudinal axis of the skull base at the
moment of impact, presumably sufficient to shear the body
of the chiasm [55]. Segal et al published a radiographic and
histopathologic demonstration of complete chiasmal transec-
tion following head trauma [56]. Other proposed mecha-
nisms include contusion with intrachiasmal hemorrhage (mi-
croscopic or gross), vascular compromise with secondary
chiasmal ischemia, or compression by herniating gyrus rec-
tus of the frontal lobe [54, 56].
The clinical presentation consists of severe visual loss
following head trauma. In the Hassan series, 10 of 19
(53 %) patients had no light perception in 1 eye combined
with a temporal hemianopia in the fellow eye [53]. None of
these patients experienced any recovery in the blind eye. Nine
patients had a bitemporal hemianopia which was typically
complete. Seventy-five percent of patients retained 20/40
(0.5) acuity in 1 eye. In a series of 10 patients reported by
Atipo et al 3 patients had relatively minor head traumawithout
associated craniofacial fractures [57]. The visual loss in these
3 patients was delayed by 0.5–11 days and visual function
(acuity and bitemporal defect) recovered in 1 patient. There is
no known treatment for traumatic chiasmal syndrome and
management usually focuses on other associated aspects of
trauma. Treatment with high dose corticosteroids is sometimes
used but there is no evidence demonstrating efficacy.
Due to its protected position, trauma sufficient to damage
the chiasm usually causes other deficits. These include diabe-
tes insipidus and/or pituitary dysfunction in about one-third of
patients and cranial neuropathy in over half of patients (ocu-
lomotor nerve palsy in 53 %, abducens nerve palsy 47 %,
trochlear nerve palsy 21 %, and anosmia 21 %). Two patients
in the series of Hassan et al also had deficits of cranial nerve V,
VII, and VIII [53].
An unusual form of chiasmal trauma in a patient undergo-
ing treatment for a retinal detachment has been recently re-
ported [58]. In this rare operative complication, C3F8
perfluoropropane gas from the vitreous cavity migrated into
the optic nerve and posteriorly to the chiasm, causing visual
loss. This sequence of events is presumed due to markedly
elevated intra-ocular pressure.
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Chiasmal Herniation
The chiasm lies in the suprasellar cistern separated from the
sella turcica and pituitary gland by the diaphragma sella.
When the diaphragma sella is defective, for example, after
pituitary surgery, the suprasellar arachnoid space and its
contents including the chiasm can herniate into the sella
turcica [59] (Fig. 1b). The tethering effect of the downward-
ly displaced chiasm may cause visual loss [60]. However,
the degree of herniation does not predict the severity of
visual loss.
Delayed visual loss following dopamine agonist treat-
ment (bromocriptine, pergolide, cabergoline, and
quinagolide) of prolactinomas has been reported in asso-
ciation with chiasmal hernation secondary to rapid shrink-
age of tumor [61–63]. The response of prolactinomas to
medical therapy is very favorable with normalization of
serum prolactin levels in 70 %–100 % of patients and a
significant decrease in tumor size in 80 %–90 % [64].
This rapid involution of the tumor may result in chiasmal
prolapse, a diagnosis which is confirmed with MRI.
Jones et al described 7 patients with chiasmal herniation
following successful dopamine agonist treatment of a
macroprolactimona [61]. Before treatment, all patients had
visual loss and very high prolactin levels (median
86,000 mU/l). Following treatment, all patients demonstrated
adequate suppression of serum prolactin and radiographically-
detectable tumor reduction and visual recovery. Within a
median time of 10 months (range 4–120 months), all patients
developed recurrent visual loss without evidence of tumor
recurrence. In each case, chiasmal herniation was identified
as the most likely cause of recurrent visual loss. Reduction or
withdrawal of treatment led to stabilization and/or resolution
of visual loss in all patients. The mechanism in such cases,
however, remains controversial. For example, Chuman et al
have noted that visual recovery typically occurs without a
corresponding change in the position of the chiasm. They
have, therefore, proposed that drug toxicity or ischemia due
to vasospasm, rather than mechanical traction, may be a more
plausible mechanism [63]. They recommend that symptomat-
ic chiasmal herniation following dopaminergic therapy be
treated by decreasing drug dosage rather than with surgical
intervention.
Surgical intervention in such cases attempts to lift the
chiasm out of the sella (chiasmopexy) and has been reported
to be a viable option for treating symptomatic chiasmal
hernation, particularly in patients who had undergone surgery
for their primary tumor. Various approaches including the
transcranial, transsphenoidal, or transglabellar approach, have
been described and the intervention may include fibrinolysis
of local adhesions, and/or filling of the empty sella with
material such as fat, bone, or coils to return the chiasm to a
more normal position [65–67].
Hereditary Optic Neuropathy
Leber hereditary optic neuropathy (LHON) is a maternally
inherited mitochondrial disorder affecting the optic nerves in
which the typical clinical presentation is subacute, painless,
sequential visual loss in young adult males [68]. Neuroimag-
ing of the pregeniculate visual pathway is usually normal in
patients with LHON but occasionally MRI abnormalities ap-
pear, usually weeks to months after the onset of visual loss.
Within weeks of visual loss, there may be enlargement of the
retrobulbar or intracranial optic nerves and/or chiasm [69, 70].
If there is also contrast enhancement of the affected structure,
the clinical picture may be mistaken for demyelinating optic
neuritis or chiasmal neuritis.
In other patients, MRI shows high T2 signal in normal-
sized or moderately enlarged prechiasmal optic nerves, chi-
asm and even optic tracts [71•]. Similar increased signal also
can also be seen on short time inversion recovery sequences
(STIR). These MRI changes appear in the subacute clinical
phase, usually several months after visual loss, and may
persist for several months. Batoglu et al published a photo
essay of a patient with the 11778 mutation for LHON and
sequential visual loss [72]. The MRI T2-hyperintensity first
appeared in the right side of the chiasm 3 months after visual
loss in the right eye and 6 months later developed to bilateral
hyperintense signal within the body of the chiasm. No en-
largement or contrast enhancement of the optic nerves or
chiasm was noted. It has been proposed that the increased
T2 signal represents local edema and demyelination in the
subacute phase followed by gliosis in the chronic phase of
disease [71•, 72].
Occasionally, other forms of hereditary optic neuropathy
may also produce chiasmal clinical features, though not con-
firmed with radiographic findings. We have seen 2 patients
with Wolfram’s syndrome (diabetes mellitus, diabetes
insipidus, deafness, and optic atrophy) whose progressive
visual loss took the form of bitemporal hemianopic defects.
Conclusions
The optic chiasm is subject to compression by extrinsic mass
lesions involving surrounding structures. However, a variety
of other (noncompressive) processes can also involve the
chiasm. In such cases, the clinical features usually point to
the correct localization of the disease process but advances in
neuroimaging have enabled us to confirm the suspected site
and often provide additional diagnostic information.
MRI has been extremely useful for identifying inflamma-
tion and neoplasia of the chiasm. However, though MRI
images are highly sensitive, they are not particularly specific.
Thus, inflammation, demyelination, and tumor are accompa-
nied by similar radiological changes, typically consisting of
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enlargement and/or enhancement of the body of the chiasm.
Radiation necrosis also produces similar changes onMRI. We
therefore routinely use clinical information along with the
radiologic findings to arrive at a diagnosis and to help guide
treatment. Chiasmal ischemia and infarction are uncommon
and require more specialized radiographic techniques.
Chiasmal hemorrhage is readily seen on noncontrast CT
images.
In addition, recent reports have demonstrated that
mitochondrial-related optic neuropathies (specifically, Leber
hereditary optic neuropathy and ethambutol toxicity) may also
induce signal changes within the body of the chiasm. In some
of these cases of metabolic dysfunction, the radiographic
findings are accompanied by clinical features of chiasmal
dysfunction.
Our clinical judgment is based in part on the likelihood of a
particular condition. When the clinical findings indicate a
chiasmal syndrome, we proceed with neuroimaging, antici-
pating that we will find a benign skull base tumor. We some-
times share this educated guess with patients so that they will
be partly prepared for receiving the diagnosis. When the scan
fails to reveal the expected compressive mass, we should have
a fallback plan: what else could produce these signs and
symptoms? We hope that the information reviewed in this
paper helps the physician in this clinical scenario.
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